APA
Ntalas I. V., Kalantzi K. I., Tsoumani M. E., Vakalis J. N., Vasilakopoulos V., Vardakis K., Vemmos K. N., Voukelatou M., Giannakoulas G., Giatrakos I., Giogiakas V., Goumas G., Dimoulis N., Draganigos A., Efthimiadis I., Thoma M., Kazakos E., Kipouridis N., Konstantinou S., Bourdakis A., Nikolopoulos D., Peltekis L., Prokopakis N., Sinteles I., Stroumbis C. S., Terzoudi K., Tsilias K., Xaraktsis I., Charmpas C., Hatziathanasiou G., Christogiannis Z., Panagiotakos D. B., Goudevenos J. A. & Tselepis A. D. (20160719). Generic Clopidogrel Besylate in the Secondary Prevention of Atherothrombotic Events: A 6-month Follow-up of a Randomised Clinical Trial. : Current vascular pharmacology.
Chicago
Ntalas Ioannis V, Kalantzi Kalliroi I, Tsoumani Maria E, Vakalis John N, Vasilakopoulos Vasileios, Vardakis Konstantinos, Vemmos Konstantinos N, Voukelatou Maria, Giannakoulas Georgios, Giatrakos Ioannis, Giogiakas Vasileios, Goumas Georgios, Dimoulis Nikos, Draganigos Antonios, Efthimiadis Ioannis, Thoma Maria, Kazakos Evangelos, Kipouridis Nikolaos, Konstantinou Spiros, Bourdakis Adamantios, Nikolopoulos Dimitrios, Peltekis Leonidas, Prokopakis Nikos, Sinteles Ioannis, Stroumbis Christos S, Terzoudi Kyriafina, Tsilias Karmelos, Xaraktsis Ioannis, Charmpas Christos, Hatziathanasiou Georgios, Christogiannis Zacharias, Panagiotakos Demosthenes B, Goudevenos John A and Tselepis Alexandros D. 20160719. Generic Clopidogrel Besylate in the Secondary Prevention of Atherothrombotic Events: A 6-month Follow-up of a Randomised Clinical Trial. : Current vascular pharmacology.
Harvard
Ntalas I. V., Kalantzi K. I., Tsoumani M. E., Vakalis J. N., Vasilakopoulos V., Vardakis K., Vemmos K. N., Voukelatou M., Giannakoulas G., Giatrakos I., Giogiakas V., Goumas G., Dimoulis N., Draganigos A., Efthimiadis I., Thoma M., Kazakos E., Kipouridis N., Konstantinou S., Bourdakis A., Nikolopoulos D., Peltekis L., Prokopakis N., Sinteles I., Stroumbis C. S., Terzoudi K., Tsilias K., Xaraktsis I., Charmpas C., Hatziathanasiou G., Christogiannis Z., Panagiotakos D. B., Goudevenos J. A. and Tselepis A. D. (20160719). Generic Clopidogrel Besylate in the Secondary Prevention of Atherothrombotic Events: A 6-month Follow-up of a Randomised Clinical Trial. : Current vascular pharmacology.
MLA
Ntalas Ioannis V, Kalantzi Kalliroi I, Tsoumani Maria E, Vakalis John N, Vasilakopoulos Vasileios, Vardakis Konstantinos, Vemmos Konstantinos N, Voukelatou Maria, Giannakoulas Georgios, Giatrakos Ioannis, Giogiakas Vasileios, Goumas Georgios, Dimoulis Nikos, Draganigos Antonios, Efthimiadis Ioannis, Thoma Maria, Kazakos Evangelos, Kipouridis Nikolaos, Konstantinou Spiros, Bourdakis Adamantios, Nikolopoulos Dimitrios, Peltekis Leonidas, Prokopakis Nikos, Sinteles Ioannis, Stroumbis Christos S, Terzoudi Kyriafina, Tsilias Karmelos, Xaraktsis Ioannis, Charmpas Christos, Hatziathanasiou Georgios, Christogiannis Zacharias, Panagiotakos Demosthenes B, Goudevenos John A and Tselepis Alexandros D. Generic Clopidogrel Besylate in the Secondary Prevention of Atherothrombotic Events: A 6-month Follow-up of a Randomised Clinical Trial. : Current vascular pharmacology. 20160719.